« Back
Home /
Inetetamab

Inetetamab

Item no.	HY-P99969-5mg
Manufacturer	MedChem Express
Amount	5 mg
Category	Antibodies In Vivo Antibodies
Type	Antibody Monoclonal
Specific against	other
Purity	96.54
Dry ice	Yes
Citations	[1]Min Yan, et al. Anti-HER2 antibody inetetamab plus camrelizumab and utidelone for pretreated HER2-positive advanced breast cancer: A single-arm, multicenter, phase 2 study. Journal of Clinical Oncology. 2022. 40 (16), e13030-e13030. <br>[2]Deng L,et al. Systemic investigation of inetetamab in combination with small molecules to treat HER2-overexpressing breast and gastric cancers. Open Life Sci. 2023 Jan 10;18(1):20220535.
Smiles	[Inetetamab]
ECLASS 10.1	42030590
ECLASS 11.0	42030590
UNSPSC	12352203
Available
Product Description	Inetetamab is a monoclonal antibody binding to domain IV of HER2 receptor. Inetetamab alone or together with tyrosine kinase inhibitors has antitumor activities[1][2].
StorageTemperature	Store at -80°C for 2 years
Shipping	Dry Ice
Manufacturers Applications	Cancer-Kinase/protease
MolecularWeight	N/A
Clinical_Information	Phase 4
Manufacturers Research_Area	Cancer
Solubility	10 mM in DMSO
Isoform	ErbB2/HER2
Pathway	JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Manufacturers Product type	Inhibitory Antibodies

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 5 mg

available

Request delivery time